The atypical clinical presentation of the patient, microphthalmia and vitreous hyperplasia which are not associated with dystrophynopathy, encompass some forms of congenital muscular dystrophy caused by glycosylation defects of α-dystroglycan. This evidence concerns the gene DAG1 and microphthalmia.